Literature DB >> 8864735

Epithelial dysplasia and squamous cell carcinoma of the Wistar rat palatal mucosa: 4NQO model.

J M Nauta1, J L Roodenburg, P G Nikkels, M J Witjes, A Vermey.   

Abstract

BACKGROUND: The carcinogen 4-nitroquinoline 1-oxide (4NQO) has been used in several studies concerning experimental oral carcinogenesis to induce squamous cell carcinoma in the palatal mucosa of rats, whereas limited attention has been paid to preceding premalignant mucosal changes. The aim of this study was to describe the macroscopic and microscopic changes of the rat palatal mucosa treated with 4NQO as a function of the application time of this carcinogen.
METHODS: The carcinogen 4NQO was applied to the palatal mucosa of male Wistar rats three times a week for 2-26 weeks. The Epithelial Atypia Index (EAI) was used to quantify the degree of dysplasia induced by the application of 4NQO for various time intervals.
RESULTS: This study shows that the EAI increases as a function of the application time. As soon as 2 weeks following application of the carcinogen, dysplastic alterations in the mucosa were observed. The extent and grade of the dysplastic changes increased with time. At week 26, squamous cell carcinoma developed. In rats in which the application of 4NQO was discontinued earlier, the application period appeared to be in inverse proportion to the latency period i.e., the period between the last application of the carcinogen and the first clinical sign of squamous cell carcinoma. This emphasizes the premalignant character of the induced epithelial changes, because in all the rats squamous cell carcinoma eventually developed.
CONCLUSIONS: From this study, we concluded that the 4NQO rat palate model is a proper model in which both premalignant epithelial lesions and squamous cell carcinoma of the oral mucosa can be studied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864735     DOI: 10.1002/(SICI)1097-0347(199609/10)18:5<441::AID-HED7>3.0.CO;2-5

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta.

Authors:  S Tannehill-Gregg; E Kergosien; T J Rosol
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

2.  FDG-PET/CT of head and neck squamous cell carcinoma in a rat model.

Authors:  Karine Aubry; Ziyang Shao; Jacques Monteil; François Paraf; Jean Pierre Bessède; Michel Rigaud
Journal:  Mol Imaging Biol       Date:  2008-11-25       Impact factor: 3.488

3.  Oral carcinogenesis and oral cancer chemoprevention: a review.

Authors:  Takuji Tanaka; Mayu Tanaka; Takahiro Tanaka
Journal:  Patholog Res Int       Date:  2011-05-22

4.  Chemopreventive effects of the polyunsaturated fatty acids omega-3 on the carcinogenesis process of the upper aerodigestive tract induced by 4-nitroquinoline-1-oxide in Swiss mice.

Authors:  Ricardo Ribeiro Gama; Allan Giovanini; Fernanda Scarmato de Rosa; Daniel Cury Ogata; André Luiz Vettore de Oliveira; Ana Flávia Cardoso Costa; Carolina Talini; Denise Feniman; Douglas Kamei; Celso Felipe Júnior; Allan Coco; André Lopes Carvalho
Journal:  Ecancermedicalscience       Date:  2014-01-29

5.  Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats.

Authors:  Xiangli Kong; Xiaoqin Yang; Jinglin Zhou; Sixiu Chen; Xiaoyu Li; Fan Jian; Pengchi Deng; Wei Li
Journal:  Oncol Lett       Date:  2014-10-15       Impact factor: 2.967

Review 6.  Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma.

Authors:  Zhen-Ge Lei; Xiao-Hua Ren; Sha-Sha Wang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Onco Targets Ther       Date:  2016-01-27       Impact factor: 4.147

7.  A mouse model for oral squamous cell carcinoma.

Authors:  Remilio A L Schoop; Mathieu H M Noteborn; Robert J Baatenburg de Jong
Journal:  J Mol Histol       Date:  2009-08-14       Impact factor: 2.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.